|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 38/57 | (2006.01) |
| A61P 9/10 | (2006.01) | ||
| A61P 41/00 | (2006.01) |
| (11) | Number of the document | 1965831 |
| (13) | Kind of document | T |
| (96) | European patent application number | 06824316.1 |
| Date of filing the European patent application | 2006-12-19 | |
| (97) | Date of publication of the European application | 2008-09-10 |
| (45) | Date of publication and mention of the grant of the patent | 2011-07-13 |
| (46) | Date of publication of the claims translation | 2011-11-25 |
| (86) | Number | PCT/NL2006/050321 |
| Date | 2006-12-19 |
| (87) | Number | WO 2007/073186 |
| Date | 2007-06-28 |
| (30) | Number | Date | Country code |
| 05112630 | 2005-12-21 | EP | |
| 760944 P | 2006-01-23 | US |
| (72) |
MANNESSE, Maurice, NL
NUIJENS, Johannes Henricus, NL
PIEPER, Frank, NL
DE SIMONI, Maria Grazia, IT
ZIERE, Gijsbertus Johannes, NL
|
| (73) |
Pharming Intellectual Property B.V.,
Darwinweg 24, 2333 CR Leiden,
NL
|
| (74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | C1 inhibitoriaus panaudojimas išeminio-reperfuzinio pažeidimo prevencijai |
| USE OF C1 INHIBITOR FOR THE PREVENTION OF ISCHEMIA-REPERFUSION INJURY |
| Payment date | Validity (years) | Amount | |
| 2024-12-03 | 19 | 347.00 EUR |
| 2025-12-19 |